AquaBounty Technologies (NASDAQ:AQB) Receives Daily News Sentiment Rating of 0.02

Media headlines about AquaBounty Technologies (NASDAQ:AQB) have been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern scores the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. AquaBounty Technologies earned a media sentiment score of 0.02 on Accern’s scale. Accern also gave news articles about the company an impact score of 45.0604422394628 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Shares of AquaBounty Technologies (NASDAQ AQB) opened at $2.69 on Tuesday. AquaBounty Technologies has a 52 week low of $2.25 and a 52 week high of $18.56. The company has a current ratio of 3.19, a quick ratio of 3.15 and a debt-to-equity ratio of 0.15.

In other news, major shareholder Randal J. Kirk bought 1,538,461 shares of AquaBounty Technologies stock in a transaction dated Wednesday, January 17th. The stock was bought at an average price of $3.25 per share, for a total transaction of $4,999,998.25. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. 2.60% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION WARNING: This report was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/13/aquabounty-technologies-aqb-receives-daily-news-sentiment-rating-of-0-02.html.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc, a biotechnology company, develops and markets products to enhance productivity in aquaculture. Its lead product is the AquAdvantage Salmon, a genetically modified animal for human consumption. The company was formerly known as Aqua Bounty Farms, Inc and changed its name to AquaBounty Technologies, Inc in June 2004.

Insider Buying and Selling by Quarter for AquaBounty Technologies (NASDAQ:AQB)

Receive News & Ratings for AquaBounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AquaBounty Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply